Search the Newsreel

Core Laboratories (NYSE:CLB) Stock Rating Upgraded by Johnson Rice

Johnson Rice upgraded Core Laboratories (NYSE:CLB) from a "hold" to a "buy" rating, setting a $21.00 price target. This upgrade implies a significant upside, although the broader analyst consensus remains "Hold." The company recently reported better-than-expected EPS but missed revenue estimates, while its CEO …

Stevanato Group S.p.A. (STVN) Stock Forecasts

Morningstar has initiated coverage on Stevanato Group S.p.A. (STVN) with a narrow moat rating and a fair value estimate of USD 21.10. The shares are currently considered fairly valued at their current price of 21.52. Stevanato Group provides glass and polymer drug containment, drug …

Dr. Reddy’s Laboratories (RDY) CEO API & Services Deepak Sapra resigns effective November 12, 2026

Dr. Reddy’s Laboratories announced that Deepak Sapra, CEO of API & Services and a Senior Management Personnel, has resigned to pursue outside opportunities. His resignation is effective November 12, 2026, and he will remain with the company until then to ensure a smooth transition …

Silicon Labs: Medical Revenue Surges 78% To Record As IoT Design Wins Accelerate

Silicon Labs reported a record 78% year-over-year increase in Medical revenue for Q2, driven by accelerating IoT design wins and stronger demand across its portfolio. Total Q2 revenue rose 18% to $228 million, with significant growth in Industrial & Commercial and Home & Life …

Abbott Laboratories (NYSE:ABT) Raised to Outperform at Wolfe Research

Wolfe Research upgraded Abbott Laboratories (NYSE:ABT) to "outperform" from "peer perform," setting a $130 price target, which suggests a 17.2% upside. This upgrade comes after Abbott's recent quarterly results surpassed expectations, with EPS of $1.31 and revenue of $12.59 billion, an increase of 13% …

Dev Accelerator Posts Q1 FY27 Earnings Call Audio for Investor Access

What's Backing Abbott's Established Pharmaceuticals Division Growth

Abbott Laboratories' ABT Established Pharmaceuticals Division ("EPD") continues to be a solid growth contributor, supported by its broad portfolio of branded generic medicines and strong commercial presence across emerging markets. In the second quarter of 2026, EPD sales increased 8.4% on a reported basis …

Wolfe Research downgrades Stryker, upgrades Abbott in med-tech shuffle

Investing.com -- Wolfe Research made two rating changes across large-cap medical devices, downgrading Stryker while upgrading Abbott Laboratories on Thursday. Analyst Mike Polark cut Stryker to Peer Perform, citing a demanding second-half setup following the company's March cyber disruption. He said the June quarter …

Kratos Defense Could Be a Huge Winner in Autonomous Warfare

Kratos Defense (NASDAQ: KTOS) is positioning itself across autonomous aircraft, propulsion, and satellite software as the Pentagon pursues affordable military systems at scale. The opportunity could be enormous, but its future depends on converting proven technology into sustained production and revenue. Stock prices used …

Here Are Thursday’s Top Wall Street Analyst Research Calls: Abbott Labs, AbbVie, Akamai Technologies, Five Below, Keurig Dr. Pepper, Salesforce, Stryker, StubHub, and More

This article details Wall Street analyst upgrades, downgrades, and initiations for various companies on Thursday, August 13, 2026, following the release of inline CPI data. Key movements include Five Below being upgraded to Buy at Jefferies and StubHub being cut to Underperform at Bank …

Die Abbott-Laboratories-Aktie legt nach starken Quartalszahlen und solider Guidance zu

Atomo Diagnostics Limited (ASX:AT1) Share Price Remains Unchanged as Stock Trades Within Daily Range

JHS Svendgaard Q1 Results: Net profit rises 156% YoY to ₹24 lakh

Silicon Labs (SLAB) Stock Looks Above Fair Value After A 67% Run

Silicon Laboratories (SLAB) stock has seen a 67.3% return over the last year, but current valuations suggest it may be above fair value. Trading at a P/S ratio of 8.8x, higher than the industry average, the stock screens as overvalued. While recent revenue and …

Wasatch Advisors LP Increases Position in Mesa Laboratories, Inc. $MLAB

Wasatch Advisors LP significantly increased its stake in Mesa Laboratories, Inc. (NASDAQ:MLAB) by 125.8% in the second quarter, now owning 115,668 shares valued at $11.5 million. This comes as other institutional investors also adjusted their positions in the medical instruments supplier. Despite an overall …

What Dolby Laboratories (DLB)'s Dolby Vision 2 TV Rollout and VVC IP Push Mean For Shareholders

V. M. Manning & CO. Inc. Acquires New Position in Abbott Laboratories $ABT

V. M. Manning & CO. Inc. has acquired a new stake in Abbott Laboratories, purchasing 19,849 shares valued at approximately $1.8 million, making it their 11th largest holding. This move comes as Abbott Laboratories exceeded its quarterly earnings expectations and maintains a positive outlook …

McCollum Christoferson Group LLC Sells 62,644 Shares of Abbott Laboratories $ABT

United Laboratories Schedules Board Meeting to Approve 2026 Interim Results

Lucro da Equatorial (EQTL3) recua 83,5% no 2º trimestre

Core Laboratories Inc. (CLB) stock price, news, quote and history

Bio-Rad Laboratories, Inc. (NYSE:BIO) Receives Consensus Rating of "Reduce" from Brokerages

IDEXX (IDXX) Stock Looks Fair On Cash Flow But Rich On Earnings

Abbott Laboratories $ABT Shares Acquired by DAVENPORT & Co LLC

IPCALAB: Net profit surged 80% year-over-year on strong revenue and margin expansion across key segments

Assenagon Asset Management S.A. Increases Stock Position in Kratos Defense & Security Solutions, Inc. $KTOS

Assenagon Asset Management S.A. significantly increased its stake in Kratos Defense & Security Solutions, Inc. (NASDAQ:KTOS) by 80.2% in the second quarter, bringing its total holdings to 70,254 shares valued at $3.5 million. This move comes as other institutional investors have also adjusted their …

10-Day Rally Sends Kratos Defense & Security Solutions Stock Up 45%

Plato Income Maximiser (ASX:PL8): Dividend Stock to Watch as It Goes Ex-Dividend Tomorrow

Horace Mann Educators Corporation $HMN Shares Sold by Amundi

Amundi reduced its stake in Horace Mann Educators Corporation (NYSE:HMN) by 75.1% in the first quarter, selling 24,286 shares. Despite this, other institutional investors have increased their holdings, and 99.28% of the stock is owned by institutions and hedge funds. Horace Mann Educators recently …

Abbott Laboratories Aktie | US0028241000 | ETR:ABL | News & Aktienkurs | FRA:ABL

Brooks Laboratories sets remote e-voting window for September 3 AGM

Dr. Reddy's Laboratories advances Thursday, outperforms competitors

Shares of Dr. Reddy's Laboratories Ltd. (500124) increased by 0.59% to 1,206.00 Indian rupees on Thursday. This occurred during a positive trading session for the stock market, with the BSE SENSEX Index (1) rising by 0.15%. The company's shares closed 14.73% below their 52-week …

Ipca Laboratories shares gain over 2% to Rs 1,802.60

Rep. Mike Kelly Unloads Abbott Laboratories (NYSE:ABT) Shares

Representative Mike Kelly sold shares of Abbott Laboratories (NYSE:ABT) valued between $1,001 and $15,000 on July 17th, as well as shares of PepsiCo and Walt Disney on the same day. This sale occurred despite Abbott Laboratories reporting a quarterly earnings beat and reaffirming its …

Atour Lifestyle (ATAT) to Announce Quarterly Earnings on Thursday

Atour Lifestyle (NASDAQ:ATAT) is scheduled to announce its Q2 2026 earnings before market open on Thursday, August 20th. Analysts are anticipating an EPS of $0.57 and revenue of $476.76 million. The company previously surpassed expectations in its last quarter, and Wall Street maintains a …

KTOS Stock Falls After Hours, But Retail Highly Optimistic About Growth